S&P 500 Pushes Toward 25% Gain Since March 9th
At 842, the S&P is pushing near a 25% gains since it bottomed for the year-to-date at 677 on March 9th. The bank stocks continue an extraordinary run over that period. Citigroup…
At 842, the S&P is pushing near a 25% gains since it bottomed for the year-to-date at 677 on March 9th. The bank stocks continue an extraordinary run over that period. Citigroup…
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover target. There is roughly $150 billion in new equity investor capital that…
According to Reuters, Obama faces backlash due to AIG (AIG) compensation issues which could set bank his efforts to salvage the financial system. Reuters reports that Lehman will put two of its…
Merck (MRK) is merging with Schering-Plough (SGP) in a deal that the companies say is worth $41.1 billion. In reality, Merck is making an acquisition. Its shares will be the currency to…
It’s another rough trading day in the stock market. It is bad enough that the DJIA is down over 3% to decade lows and under 7,000… But even almost all of the…
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know is if these results — or more importantly its guidance — show…
It looks like we have our most likely candidates for the "Dogs of the Dow" for 2009. This is often misunderstood as an investment vehicle. These are the 10 highest dividend-yielding stocks…
The Dogs of the Dow are often misunderstood as an investment vehicle. These are technically the 10 highest dividend-yielding stocks out of the 30 DJIA components. The formal list of the ten…
People who get to the end of 2008 and are still at work can be thankful. The unemployment rate will probably be over 7%. That does not count the people no longer…
According to Reuters, the House will vote on the auto bailout as early as this week. Reuters writes that Rio Tinto (RTP) will cut 14,000 jobs. Reuters reports that AIG (AIG) owes…
Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week. Merck plans to emerge next year and into the next decade leaner and…
It is easy to get pumped up about overseas rate cuts, but there is cautionary data from at least three DJIA components. Wal-Mart is the economic trade-down so that win in retail…
So much fore feeling better in a bad economy. Merck (MRK) offered lackluster guidance for next year and the stock is off before the open. According to Reuters, "Merck said it expected…
According to Reuters, former Citigroup (C) CEO Sandy Weill may start a fund to invest in distressed financial companies. Reuters writes that Amazon (AMZN) turned in a weak forecast hurting its stock.…
Dynavax Technologies Corp. (NASDAQ: DVAX) is the latest biotech implosion as shares are down some 75% today. The company gave an update on an FDA clinical hold on its investigational vaccine HEPLISAV…